He is the head of HHS, and yet he continues to spout untested, unproven therapies and has only given a very lukewarm ...

Now, he is warning of a fundamental change at HHS and the FDA—one he believes is already proving to be very dangerous. “What I saw at the agency was an increasing anti-vaccine tone," he told ...

The FDA has released its recommendations on the ... meet to discuss the strains that should be included in the seasonal vaccine yesterday but was abruptly cancelled by new Health and Human ...

With former director of the FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., out of the picture, ...

The study’s results indicated the cumulative incidence of influenza – or the number of new cases divided by the total number ...

The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

The Food and Drug Administration is reportedly considering shifting large swaths of its core function to states after mass ...

China is not as big a player in the manufacturing of key ingredients used to make brand and generic medicines as previously ...

With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmithKline's venerable vaccine Priorix for sale in the US looks timely. Priorix was first launched in Europe ...

An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.

Experts underscore the importance of MMR vaccinations to prevent the spread of measles and bolster collective immunity.